New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

NCT00393952 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

557

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone propionate/Formoterol fumarate 250/10
DRUG: Placebo
DRUG: Fluticasone propionate/Formoterol fumarate 100/10
DRUG: Fluticasone propionate 250
DRUG: Formoterol fumarate 10

Sponsor

SkyePharma AG